146 related articles for article (PubMed ID: 11075843)
1. Rizatriptan wafer--sublingual vs. placebo at the onset of acute migraine.
Klapper JA; O'Connor S
Cephalalgia; 2000 Jul; 20(6):585-7. PubMed ID: 11075843
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group.
Ahrens SP; Farmer MV; Williams DL; Willoughby E; Jiang K; Block GA; Visser WH
Cephalalgia; 1999 Jun; 19(5):525-30. PubMed ID: 10403069
[TBL] [Abstract][Full Text] [Related]
3. Rizatriptan wafer--sublingual vs. placebo at the onset of acute migraine.
Allen C; Dayno J; Lines C; McCarroll K
Cephalalgia; 2001 Feb; 21(1):77. PubMed ID: 11298669
[No Abstract] [Full Text] [Related]
4. Long-term efficacy and tolerability of rizatriptan wafers in migraine.
Cady R; Crawford G; Ahrens S; Hairwassers D; Getson A; Visser WH; Lines C;
MedGenMed; 2001 Jun; 3(3):1. PubMed ID: 11549974
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment.
Freitag F; Diamond M; Diamond S; Janssen I; Rodgers A; Skobieranda F
Headache; 2008 Jun; 48(6):921-30. PubMed ID: 18572432
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled evaluation of the effect of oral doses of rizatriptan 10 mg on oral contraceptive pharmacokinetics in healthy female volunteers.
Shadle CR; Liu G; Goldberg MR
J Clin Pharmacol; 2000 Mar; 40(3):309-15. PubMed ID: 10709161
[TBL] [Abstract][Full Text] [Related]
7. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study.
Winner P; Lewis D; Visser WH; Jiang K; Ahrens S; Evans JK;
Headache; 2002 Jan; 42(1):49-55. PubMed ID: 12005275
[TBL] [Abstract][Full Text] [Related]
8. Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group.
Teall J; Tuchman M; Cutler N; Gross M; Willoughby E; Smith B; Jiang K; Reines S; Block G
Headache; 1998 Apr; 38(4):281-7. PubMed ID: 9595867
[TBL] [Abstract][Full Text] [Related]
9. Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine.
Pascual J; Bussone G; Hernandez JF; Allen C; Vrijens F; Patel K;
Eur Neurol; 2001; 45(4):275-83. PubMed ID: 11385269
[TBL] [Abstract][Full Text] [Related]
10. Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.
Bomhof M; Paz J; Legg N; Allen C; Vandormael K; Patel K
Eur Neurol; 1999; 42(3):173-9. PubMed ID: 10529545
[TBL] [Abstract][Full Text] [Related]
11. Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study.
Solomon S; Frishberg B; Hu XH; Markson L; Berger M
Clin Ther; 2001 Jun; 23(6):886-900. PubMed ID: 11440288
[TBL] [Abstract][Full Text] [Related]
12. Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial.
Barbanti P; Fofi L; Dall'Armi V; Aurilia C; Egeo G; Vanacore N; Bonassi S
J Headache Pain; 2012 Jul; 13(5):407-14. PubMed ID: 22460943
[TBL] [Abstract][Full Text] [Related]
13. Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.
Mannix LK; Loder E; Nett R; Mueller L; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
Cephalalgia; 2007 May; 27(5):414-21. PubMed ID: 17448179
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine.
Gijsman H; Kramer MS; Sargent J; Tuchman M; Matzura-Wolfe D; Polis A; Teall J; Block G; Ferrari MD
Cephalalgia; 1997 Oct; 17(6):647-51. PubMed ID: 9350384
[TBL] [Abstract][Full Text] [Related]
15. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
[TBL] [Abstract][Full Text] [Related]
16. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
[TBL] [Abstract][Full Text] [Related]
17. Rizatriptan 10-mg ODT for early treatment of migraine and impact of migraine education on treatment response.
Cady RK; Martin VT; Géraud G; Rodgers A; Zhang Y; Ho AP; Hustad CM; Ho TP; Connor KM; Ramsey KE
Headache; 2009 May; 49(5):687-96. PubMed ID: 19472447
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design.
Ho TW; Pearlman E; Lewis D; Hämäläinen M; Connor K; Michelson D; Zhang Y; Assaid C; Mozley LH; Strickler N; Bachman R; Mahoney E; Lines C; Hewitt DJ;
Cephalalgia; 2012 Jul; 32(10):750-65. PubMed ID: 22711898
[TBL] [Abstract][Full Text] [Related]
20. Rizatriptan in the treatment of menstrual migraine.
Silberstein SD; Massiou H; Le Jeunne C; Johnson-Pratt L; McCarroll KA; Lines CR
Obstet Gynecol; 2000 Aug; 96(2):237-42. PubMed ID: 10908770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
